Physicochemical Properties
| Molecular Formula | C10H12N4O4 |
| Molecular Weight | 252.2267 |
| Exact Mass | 252.085 |
| CAS # | 890-38-0 |
| PubChem CID | 135398593 |
| Appearance | White to off-white solid powder |
| Density | 1.9±0.1 g/cm3 |
| Boiling Point | 620.6±65.0 °C at 760 mmHg |
| Melting Point | 250 °C |
| Flash Point | 329.1±34.3 °C |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.837 |
| LogP | -1.43 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Complexity | 377 |
| Defined Atom Stereocenter Count | 3 |
| SMILES | C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CNC3=O)CO)O |
| InChi Key | VGONTNSXDCQUGY-RRKCRQDMSA-N |
| InChi Code | InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1 |
| Chemical Name | 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | 2'-deoxyadenosine is mostly deaminated to 2'-deoxyinosine and subsequently transformed into hypoxanthine in the absence of deoxycoformycin. Adenine is produced when the deoxynucleoside experiences phosphorolytic cleavage in the presence of the inhibitor, in addition to phosphorylation. When the activity of adenosine deaminase is blocked or decreased, the conversion of 2'-deoxyadenosine to adenine may arise as a defensive mechanism. Many signs point to the possibility that the enzyme enacting this process is different from methylthioadenosine phosphorylase and S-adenosyl homocysteine hydrolase, the enzymes known to be involved in the mammalian conversion of 28-deoxyadenosine to adenine[1]. |
| References |
[1]. Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin. Int J Cancer. 1998 Mar 2;75(5):713-20. |
| Additional Infomation |
2'-deoxyinosine is a purine 2'-deoxyribonucleoside that is inosine in which the hydroxy group at position 2' is replaced by a hydrogen. It has a role as a Saccharomyces cerevisiae metabolite, a human metabolite, a plant metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purines 2'-deoxy-D-ribonucleoside and a purine 2'-deoxyribonucleoside. It is functionally related to an inosine. Deoxyinosine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). 2'-Deoxyinosine has been reported in Drosophila melanogaster, Arabidopsis thaliana, and other organisms with data available. 2'-Deoxyinosine is a metabolite found in or produced by Saccharomyces cerevisiae. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~50 mg/mL (~198.23 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.91 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.91 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (9.91 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.9646 mL | 19.8232 mL | 39.6464 mL | |
| 5 mM | 0.7929 mL | 3.9646 mL | 7.9293 mL | |
| 10 mM | 0.3965 mL | 1.9823 mL | 3.9646 mL |